arrow
M

Madalina Tuluc

pathology and genomic medicine
H指数:28
被引数:2,589

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck

Nivolumab和ipilimumab联合放疗治疗高危局部晚期头颈部鳞状细胞癌

2023-08-035
OAAI
Variance in 3D anatomic localization of surgical margins based on conventional margin labeling in head and neck squamous cell carcinoma
2023-04-016
OAAI
Tadalafil Enhances Immune Signatures in Response to Neoadjuvant Nivolumab in Resectable Head and Neck Squamous Cell Carcinoma

他达拉非增强可切除头颈部鳞状细胞癌新辅助Nivolumab的免疫特征

2021-12-1430
OAAI
Spatial distribution of CD8+and FoxP3+in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (HNSCC)
2021-09-011
OAAI
Discordant Responses Between Primary Head and Neck Tumors and Nodal Metastases Treated With Neoadjuvant Nivolumab: Correlation of Radiographic and Pathologic Treatment Effect
2020-12-0230
OAAI
Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage
CANCER
IF5.1
2019-06-0728
OAAI
Metformin Clinical Trial in HPV+ and HPV- Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate

二甲双胍在HPV和HPV-头颈部鳞状细胞癌中的临床试验: 对癌细胞凋亡和免疫浸润的影响

2018-10-1132
OAAI